In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.
Ozempic Is About to Go Generic in India, China and Canada
Scritto il 19/03/2026
da Rebecca Robbins, Meaghan Tobin, Eshe Nelson, Alex Travelli and Pragati K.B.